sellWeak
James N Topper sold $1,227 of ALPN
director at ALPINE IMMUNE SCIENCES, INC.. 19 shares at an average of $64.57, traded Apr 25, 2024, filed Apr 29, 2024.
Warning score
15Value
$1,227
19 shares
Holdings after
2,829,347
-0% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- 0Trade size$1k at market
- 0Share of holdings soldSold 0.0% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-24-011664, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 25, 2024 | XIn-the-money exercise Common Stockindirect: By: Frazier Life Sciences VIII, L.P. | +1,200,000 | $0.00 | $1,200 | 2,829,366 | Apr 29, 2024 |
| Apr 25, 2024 | SOpen-market sale Common Stockindirect: By: Frazier Life Sciences VIII, L.P. | -19 | $64.57 | $1,227 | 2,829,347 | Apr 29, 2024 |
| Apr 25, 2024 | XIn-the-money exercise Warrant (Right to Buy)derivativeindirect: By: Frazier Life Sciences VIII, L.P. | -1,200,000 | $0.00 | $0 | 0 | Apr 29, 2024 |
Related signals
Other insiders at ALPINE IMMUNE SCIENCES, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | ALPINE IMMUNE SCIENCES, INC. | James Paul Rickey See Remarks | $2.8M 118,000 shares | -50000% | |
| 65Notable | ALPINE IMMUNE SCIENCES, INC. | Orbimed Advisors LLC director | $29M 1,546,347 shares | -42% | |
| 65Notable | ALPINE IMMUNE SCIENCES, INC. | Peter A. Thompson director | $29M 1,546,347 shares | -42% | |
| 25Weak | ALPINE IMMUNE SCIENCES, INC. | Mitchell Gold Executive Chairman and CEO | $20k 1,016 shares | -100% | |
| 50Moderate | ALPINE IMMUNE SCIENCES, INC. | Mitchell Gold Executive Chairman and CEO | $1.9M 91,884 shares | -243% | |
| 32Weak | ALPINE IMMUNE SCIENCES, INC. | Mitchell Gold Executive Chairman and CEO | $48k 2,402 shares | -100% | |
| 29Weak | ALPINE IMMUNE SCIENCES, INC. | James Paul Rickey See Remarks | $292k 15,213 shares | -100% | |
| 40Moderate | ALPINE IMMUNE SCIENCES, INC. | James Paul Rickey See Remarks | $1.1M 58,787 shares | -507% | |
| 43Moderate | ALPINE IMMUNE SCIENCES, INC. | Mitchell Gold Executive Chairman and CEO | $2.0M 118,000 shares | -108% | |
| 33Weak | ALPINE IMMUNE SCIENCES, INC. | James Paul Rickey See Remarks | $1.1M 70,811 shares | -111% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.